VINEETLAB vs WANBURY: Stock Comparison

Vineet Laboratories Limited vs Wanbury Ltd

Live data: 29 April 2026, 4:01 PM IST • Source: NSE and company filings

Wanbury Ltd is the larger company by market capitalisation. Vineet Laboratories Limited shows faster revenue growth and lower leverage, while Wanbury Ltd shows a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Vineet Laboratories Limited and Wanbury Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, VINEETLAB is more favourable on 2 of 10 scored metrics and WANBURY on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
WANBURY is the larger company
₹1,091 Cr vs ₹75 Cr
EPS
WANBURY has higher earnings per share
₹13.1 vs ₹-20.47
Revenue Growth (TTM YoY)
VINEETLAB has faster revenue growth
11.05% vs -19.2%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
24.5% vs -68.8%
Qtr Profit Growth
WANBURY has stronger quarterly profit growth
1,197% vs 59.2%
ROCE
WANBURY has a higher ROCE
36.6% vs -28%
Net Margin
WANBURY has a higher net margin
10.17% vs -26.92%
Operating Margin
WANBURY has a higher operating margin
14% vs -22.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVINEETLABWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVINEETLABWANBURY
Live Price₹38.55₹312.45
Day Change5.79%-5.1%
Volume2.02 L2.85 L
52-Week High₹49.99₹358.85
52-Week Low₹27.96₹161.5
Distance from 52W High-22.88%-12.93%

Valuation

MetricVINEETLABWANBURY
Market Cap₹75 Cr₹1,091 Cr
P/E Ratio0x
P/B Ratio0x
EPS₹-20.47₹13.1
Book Value₹15.84₹18.1
Dividend Yield0%0%

Growth

MetricVINEETLABWANBURY
Revenue Growth (TTM YoY)11.05%-19.2%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-68.8%24.5%
Qtr Profit Growth59.2%1,197%

Profitability & Leverage

MetricVINEETLABWANBURY
ROE76.5%
ROCE-28%36.6%
Net Margin-26.92%10.17%
Operating Margin-22.4%14%
Debt to Equity2.73x3.02x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricVINEETLABWANBURY
Promoter Holding5.98% 6.48 pp34.36%
FII Holding0.36% 0.36 pp0.89% 0.3 pp
DII Holding0.06% 0.06 pp
Public Holding93.66% 6.12 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Vineet Laboratories Limited and Wanbury Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.